A detailed history of Voya Investment Management LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 90,391 shares of PACB stock, worth $176,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,391
Previous 90,992 0.66%
Holding current value
$176,262
Previous $124,000 23.39%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $721 - $1,304
-601 Reduced 0.66%
90,391 $153,000
Q2 2024

Dec 03, 2024

BUY
$1.36 - $3.65 $817 - $2,193
601 Added 0.66%
90,992 $124,000
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $11,623 - $31,196
8,547 Added 10.37%
90,992 $124,000
Q1 2024

Dec 06, 2024

SELL
$3.52 - $9.59 $27,969 - $76,202
-7,946 Reduced 8.79%
82,445 $309,000
Q1 2024

May 15, 2024

SELL
$3.52 - $9.59 $63,131 - $171,996
-17,935 Reduced 17.87%
82,445 $309,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $279,419 - $484,889
-46,804 Reduced 31.8%
100,380 $984,000
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $392,760 - $664,781
47,723 Added 47.98%
147,184 $1.23 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $67,716 - $95,427
6,792 Added 7.33%
99,461 $1.32 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $48,291 - $73,105
6,082 Added 7.02%
92,669 $1.07 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $7,435 - $16,214
-1,892 Reduced 2.14%
86,587 $503,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $27,874 - $72,321
6,934 Added 8.5%
88,479 $391,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $37,488 - $92,942
4,447 Added 5.77%
81,545 $742,000
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $23,593 - $36,848
1,225 Added 1.61%
77,098 $1.58 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $16,109 - $22,692
-648 Reduced 0.85%
75,873 $1.94 Million
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $70,735 - $114,255
-3,172 Reduced 3.98%
76,521 $2.68 Million
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $126,887 - $246,031
4,810 Added 6.42%
79,693 $2.66 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $220,909 - $599,611
21,039 Added 39.07%
74,883 $1.94 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $6,490 - $17,746
1,798 Added 3.45%
53,844 $531,000
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $55,634 - $84,605
-20,994 Reduced 28.74%
52,046 $180,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $8,614 - $19,199
3,650 Added 5.26%
73,040 $224,000
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $54,210 - $65,642
11,785 Added 20.46%
69,390 $357,000
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $9,773 - $12,233
1,651 Added 2.95%
57,605 $349,000
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $35,738 - $70,043
8,957 Added 19.06%
55,954 $414,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $150,390 - $261,773
46,997
46,997 $247,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.